These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83 related articles for article (PubMed ID: 4106087)
1. Metabolic clearance rate of L-triiodothyronine in man: a comparison of results by single-injection and constant infusion methods. Cavalieri RR; Steinberg M; Searle GL J Clin Endocrinol Metab; 1971 Oct; 33(4):624-9. PubMed ID: 4106087 [No Abstract] [Full Text] [Related]
2. The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism. Woeber KA; Sobel RJ; Ingbar SH; Sterling K J Clin Invest; 1970 Apr; 49(4):643-9. PubMed ID: 5467580 [TBL] [Abstract][Full Text] [Related]
3. Thyroid suppression test and outcome of hyperthyroidism treated with antithyroid drugs and triiodothyronine. Yamamoto M; Igarashi T; Kimura S; Tsukamoto S; Togawa K; Ogata E J Clin Endocrinol Metab; 1979 Jan; 48(1):72-7. PubMed ID: 581766 [No Abstract] [Full Text] [Related]
4. The relationship of thyroxine turnover to other parameters of peripheral thyroid function in Graves' disease. Clifton-Bligh P; Burke G J Lab Clin Med; 1975 Jun; 85(6):922-33. PubMed ID: 48532 [TBL] [Abstract][Full Text] [Related]
5. Iodine kinetics in man--a model. Berman M; Hoff E; Barandes M; Becker DB; Sonenberg M; Benua R; Koutras DA J Clin Endocrinol Metab; 1968 Jan; 28(1):1-14. PubMed ID: 5694134 [No Abstract] [Full Text] [Related]
6. Nonthyroidal action of propylthiouracil in euthyroid, hypothyroid and hyperthyroid man. Furth ED; Rives K; Becker DV J Clin Endocrinol Metab; 1966 Mar; 26(3):239-46. PubMed ID: 4159749 [No Abstract] [Full Text] [Related]
7. Metabolic clearance rates of diiodotyrosine in man. Singer PA; Nicoloff JT J Clin Endocrinol Metab; 1972 Apr; 34(4):666-70. PubMed ID: 4111067 [No Abstract] [Full Text] [Related]
8. [The inhibition test of thyroid function with triiodothyronine in hyperthyroid patients under medical therapy: comparison of the values obtained from measures of "early" uptake and in the organic phase]. Valentini F; Reschini E; Lodeserto A; Vivarelli S; Miedico D Folia Endocrinol; 1968 Aug; 21(4):396-403. PubMed ID: 4185869 [No Abstract] [Full Text] [Related]
9. Metabolic clearance and production rates of 3,3',5-triiodothyronine in hyperthyroid, euthyroid, and hypothyroid subjects. Smallridge RC; Wartofsky L; Desjardins RE; Burman KD J Clin Endocrinol Metab; 1978 Aug; 47(2):345-9. PubMed ID: 263302 [TBL] [Abstract][Full Text] [Related]
10. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism. He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329 [TBL] [Abstract][Full Text] [Related]
11. Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities. Kuzuya N; Chiu SC; Ikeda H; Uchimura H; Ito K; Nagataki S J Clin Endocrinol Metab; 1979 Apr; 48(4):706-11. PubMed ID: 581876 [No Abstract] [Full Text] [Related]
12. Improvement of immunologic abnormalities associated with hyperthyroidism of Graves' disease during methimazole treatment. Murakami M; Koizumi Y; Aizawa T; Yamada T; Ishihara M; Hasegawa Y; Ogata H; Kamoi K; Kaneko K Horm Metab Res; 1988 Apr; 20(4):235-8. PubMed ID: 3397034 [TBL] [Abstract][Full Text] [Related]
13. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease. Izumi M; Larsen PR J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211 [TBL] [Abstract][Full Text] [Related]
14. Reappraisal of the 3,5,3'-triiodothyronine-suppression test in the prediction of long term outcome of antithyroid drug therapy in patients with hyperthyroid Graves' disease. Yamada T; Koizumi Y; Sato A; Hashizume K; Aizawa T; Takasu N; Nagata H J Clin Endocrinol Metab; 1984 Apr; 58(4):676-80. PubMed ID: 6421866 [TBL] [Abstract][Full Text] [Related]
15. Characteristics of 3,5,3'-triiodothyronine sulfate metabolism in euthyroid man. LoPresti JS; Mizuno L; Nimalysuria A; Anderson KP; Spencer CA; Nicoloff JT J Clin Endocrinol Metab; 1991 Oct; 73(4):703-9. PubMed ID: 1890147 [TBL] [Abstract][Full Text] [Related]
16. Thyroid function during pregnancy in women with past Graves' disease. Luton D; Le Gac I; Noel M; Guibourdenche J; Polak M BJOG; 2005 Nov; 112(11):1565-7. PubMed ID: 16225580 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of triiodothyronine (T3) kinetics in normal subjects, in hypothyroid, and hyperthyroid patients using specific antiserum for the determination of labeled T3 in plasma. Bianchi R; Zucchelli GC; Giannessi D; Pilo A; Mariani G; Carpi A; Toni MG J Clin Endocrinol Metab; 1978 Feb; 46(2):203-14. PubMed ID: 750602 [TBL] [Abstract][Full Text] [Related]
18. Changes in serum TSH and T4 after T3 suppression tests in patients treated for hyperthyroidism due to Graves' disease. Suematsu H; Tamai H; Esaki M; Kurokawa N; Aoki H; Matsuzuka F; Miyauchi A; Kuma K J Clin Endocrinol Metab; 1977 Nov; 45(5):1013-8. PubMed ID: 579181 [No Abstract] [Full Text] [Related]
19. [Metabolism of triiodothyronine in hyperthyroidism and in myxedema]. Zaninovich AA; Degrossi O; Pecorini V Medicina (B Aires); 1970; 30(4):380-3. PubMed ID: 5487694 [No Abstract] [Full Text] [Related]
20. [Serum thyroxine and triiodothyronine levels after a single dose and after 2-month-long thiamazole treatment of Graves' disease with reference to drug's pharmacokinetics]. Syrenicz A Ann Acad Med Stetin; 1990; 36():133-52. PubMed ID: 2099104 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]